Varex Imaging (VREX) director sells 4,510 shares, keeps 23,450

Rhea-AI Filing Summary

Varex Imaging Corp director Jay K. Kunkel sold shares in a routine open-market transaction. He sold 4,510 shares of common stock at a price of $11.14 per share. After this sale, he directly holds 23,450 shares, so he continues to maintain a significant equity stake in the company.

Insider Trade Summary

Net Seller: 4,510 shares ($50,241)

Net Sell 1 txn

Insider Kunkel Jay K.

Role Director

Sold 4,510 shs ($50K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,510	$11.14	$50K

Holdings After Transaction: Common Stock — 23,450 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kunkel Jay K.

(Last) (First) (Middle)

C/O VAREX IMAGING CORP

1678 S. PIONEER ROAD

(Street)

SALT LAKE CITY UTAH 84104

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026		S		4,510	D	$11.14(1)	23,450	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. All individual shares were sold at a price of $11.14

Remarks:

	/s/ Matthew A. Martinez, attorney-in-fact for Jay K. Kunkel	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Varex Imaging Corp (VREX) disclose for Jay K. Kunkel?

Varex Imaging Corp disclosed that director Jay K. Kunkel completed an open-market sale of common stock. He sold 4,510 shares of VREX at a price of $11.14 per share, as shown in the Form 4 insider trading report filed with regulators.

At what price did Jay K. Kunkel sell VREX shares in the latest Form 4 filing?

Jay K. Kunkel sold his Varex Imaging Corp common shares at $11.14 each. The filing notes that all 4,510 shares involved in the transaction were sold at this single price, reflecting a straightforward open-market sale rather than a range of transaction prices.

How many Varex Imaging (VREX) shares did Jay K. Kunkel sell and how many does he still own?

Jay K. Kunkel sold 4,510 shares of Varex Imaging Corp common stock. Following this sale, the Form 4 reports that he directly owns 23,450 shares. This indicates he reduced, but did not exit, his equity position in the company.

Was the recent VREX insider transaction by Jay K. Kunkel a purchase or a sale?

The recent insider transaction by Jay K. Kunkel was a sale. The Form 4 lists transaction code “S,” indicating an open-market or private sale of 4,510 Varex Imaging Corp common shares at $11.14 per share, reducing his direct holdings to 23,450 shares.

What does the transaction code “S” mean in the VREX Form 4 for Jay K. Kunkel?

In this Varex Imaging Corp Form 4, the transaction code “S” designates a sale of stock. Specifically, it refers to Jay K. Kunkel’s open-market sale of 4,510 common shares at $11.14 per share, as opposed to an option exercise, gift, or other non-sale transaction type.